Antibiotics and anti-inflammatory drugs are used to treat infections and inflammation in hospitalized patients, but these drugs alone cannot achieve a cure. Moreover, they have side effects. 5, 6 Because of the side effects of chemical antiinflammatory drugs, finding solutions to reduce inflammation in patients admitted to intensive care units can be helpful and reduce mortality in these patients. 7, 8 Melatonin is a hormone secreted in small amounts by the pituitary gland and has been shown in previous studies to have anti-inflammatory effects. 9, 10 The purpose of this minireview is to evaluate the effects of melatonin on reducing inflammation and oxidative stress in critically ill patients.
Melatonin Features
The hormone melatonin is found naturally within the body. It is also utilized as a medication which ordinarily is made artificially in a research facility. This hormone is essentially secreted by the pineal organ and controls sleep-wake cycles.
11
Information about melatonin has only recently come to light, starting in 1958 when Aaron Lerner discovered it in mammals, and then in 1981 when Alfred Lewy revealed that bright light affected it. 12 Within the human body, melatonin levels change during the daily cycle. It has a chemical formula of C13H16N2O2 and a molecular mass of 232.278 g/mol 13 and plays a role in the regulation of the circadian rhythm of several biological functions.
14 Figure 1 shows the chemical structure of melatonin.
Role of Inflammation and Oxidative Stress
Inflammation is a defensive reaction against tissue and cell damage. Reactive oxygen species (ROS), such as the superoxide anion freed by phagocytes and recruited into inflamed sites, are proposed to be a major cause of cell and tissue damage. 15, 16 In the process of inflammation, pro-inflammatory cytokines affect the production of T-cells, monocytes, neutrophils, endothelial cells, and leptin. Moreover, they have a direct effect on macrophages, and increase the activity of phagocytosis. By increasing the level of leptin, the C reactive protein is produced and causes inflammatory effects. 17 TNF-α is secreted mainly by lymphocytes, adipose tissue, muscle, and monocytes. It was one of the first cytokines to be identified and is involved in systemic inflammatory responses. 18, 19 Interleukin 6 (IL-6), produced by macrophages and adipocytes, is a cytokine that exerts many effects ranging from defense to inflammation and organ damage. 20, 21 The discharge of cytokines/chemokines actuates neutrophil recruitment and key transcription factors such as nuclear factor-kB (NF-kB) and activator protein-1 (AP-1), increasing the inflammatory reaction and tissue harm. 22 Mitochondria, cytochrome P450, and peroxisome are the main sources of reactive species in all cells. Under physiological situations, there is a steady endogenous output of reactive nitrogen intermediate (RNI) and reactive oxygen intermediate (ROI) that interact as ''signaling'' molecules for metabolism, cell cycle, and intercellular transduction pathways. 23 Therefore, controlling the conditions of inflammation and oxidative stress can help patients improve faster. The pathophysiology of inflammation and oxidative stress are shown in Figure 2 .
Role of Melatonin Supplementation on Inflammatory and

Role of Melatonin in Inflammation and Oxidative Stress
Though initially thought to be produced exclusively in the pineal gland, melatonin (N-acetyl-5-methoxytryptamine) secretion has been found in other organs, such as the retina, bone marrow, and bile. 24 High levels of melatonin have not been found in these organs, but its secretion is not confined to the pineal gland and has been shown to lead to anti-inflammatory effects through several pathways. 24 It is an established fact that the endocrine and nervous systems can interact with the immune system in order to modulate its function 25 ; many hormones, neuroendocrine factors, and neurotransmitters can actually improve the function of the immune system. 26 Melatonin is also able to improve immune situations through its neuroendocrine function. It acts as a regulator of circadian rhythms 26, 27 in a hormone-like mold by influencing target cells and balancing other capacities depending on the photoperiod counting control of photoperiodic motions of the immune/ inflammatory reaction. 28 Alamili et al showed that melatonin administration in sepsis patients can reduce the levels of proinflammatory markers such as IL-1β. 29 In one animal study, the use of melatonin in mice with septic shock at a dose of 10 mg/kg twice daily for 3 days reduced pro-inflammatory factors of TNF-α and IL-6. 30 In another study, melatonin at a dose of 20 mg/d for 72 days in neonates with septic shock reduced the levels of C-reactive protein, white blood cells, and lipid peroxidation, and ultimately reduced infant mortality. 31 Gitto et al reported that supplementation with 10 mg/kg of body weight of melatonin for 7 days in newborns with respiratory distress syndrome decreased lipid peroxidation, reduced nitrite and nitrate levels, and decreased TNF-α and interleukin 6 and 8 levels. 32 Therefore, it seems that melatonin has had a positive effect on the reduction of inflammation and oxidative stress in previous studies, but these effects have not yet been fully proven.
Conclusions
Inflammation and oxidative stress are major factors in reducing the recovery rate and increasing mortality among critically ill patients hospitalized in intensive care units. Studies have shown that the use of melatonin in safe doses can reduce the rate of inflammation and oxidative stress and ultimately reduce the rate of mortality, but more clinical trials are needed to confirm this result.
